Red-cell aplasia due to antibodies against human recombinant erythropoietin (rHuEPO) in a peritoneal dialysis patient treated with rHuEPO.
García
Ramón R
RR
Miguel Carrasco
A
A
Tormo Díaz
M
M
Torregrosa Maicas
I
I
Pérez-Contreras
J
J
D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000188:drug therapy; D000906:Antibodies / Q000276:immunology; D004921:Erythropoietin / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D007154:Immune System Diseases / Q000139:chemically induced*; D008297:Male; D010530:Peritoneal Dialysis / Q000379:methods*; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced* / Q000276:immunology*
D000906:Antibodies; D011994:Recombinant Proteins; D004921:Erythropoietin